January 29, 2018 / 11:23 AM / in 9 minutes BRIEF-Invivo Therapeutics Says There Is Substantial Doubt About Ability To Continue As A Going Concern Reuters Staff 1 Min Read 
Jan 29 (Reuters) - Invivo Therapeutics Holdings Corp : 
* INVIVO THERAPEUTICS SAYS “THERE IS SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO CONTINUE AS A GOING CONCERN” - SEC FILING 
* INVIVO THERAPEUTICS - CURRENT CASH RESOURCES WILL NOT BE SUFFICIENT TO COMPLETE CLINICAL DEVELOPMENT OF NEURO-SPINAL SCAFFOLD IMPLANT Source text: ( bit.ly/2rOeCK6 ) Further company coverage: